These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 10946901)
41. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314 [TBL] [Abstract][Full Text] [Related]
42. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765 [TBL] [Abstract][Full Text] [Related]
43. Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma. Schteingart DE; Tsao HS J Clin Endocrinol Metab; 1980 May; 50(5):961-6. PubMed ID: 6246139 [TBL] [Abstract][Full Text] [Related]
44. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996 [TBL] [Abstract][Full Text] [Related]
45. Cushing's syndrome. How to pinpoint and treat the underlying cause. Felicetta JV Postgrad Med; 1989 Dec; 86(8):79-85, 89-90. PubMed ID: 2555800 [TBL] [Abstract][Full Text] [Related]
46. Laparoscope resection of ectopic corticosteroid-secreting adrenal adenoma. Wang XL; Dou JT; Gao JP; Zhong WW; Jin D; Hui L; Lu JM; Mu YM Neuro Endocrinol Lett; 2012; 33(3):265-7. PubMed ID: 22635081 [TBL] [Abstract][Full Text] [Related]
47. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956 [TBL] [Abstract][Full Text] [Related]
48. Exacerbation of rheumatoid arthritis after removal of adrenal adenoma in Cushing's syndrome. Yakushiji F; Kita M; Hiroi N; Ueshiba H; Monma I; Miyachi Y Endocr J; 1995 Apr; 42(2):219-23. PubMed ID: 7627266 [TBL] [Abstract][Full Text] [Related]
49. Cushing's syndrome due to a large adrenocortical adenoma with histological features simulating ACTH-independent macronodular adrenocortical hyperplasia. Karasawa R; Hotta M; Aiba M; Takano K Pathol Int; 2004 Apr; 54(4):273-8. PubMed ID: 15028030 [TBL] [Abstract][Full Text] [Related]
51. Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma. Park SY; Rhee Y; Youn JC; Park YN; Lee S; Kim DM; Song SY; Lim SK Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):13-6. PubMed ID: 17286228 [TBL] [Abstract][Full Text] [Related]